Clinical Trial: A Clinical Study to Evaluate the Efficacy of Native CT-II(R) in Individuals With Knee Osteoarthritis

U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06917287) titled 'A Clinical Study to Evaluate the Efficacy of Native CT-II(R) in Individuals With Knee Osteoarthritis' on April 01.

Brief Summary: This randomized, double-blind, placebo-controlled clinical study evaluates the efficacy of Native CT-II(R) (undenatured type II collagen) in individuals with knee osteoarthritis using a parallel design.Participants are assigned to one of three groups:

Group 1 receives Native CT-II(R) (40 mg daily individed doses), Group 2 receives Glucosamine HCL + Chondroitin Sulphate (2700 mg daily as acomparator), and Group 3 receives a placebo (Microcrystalline Cellulose). All participants take threecapsules after br...